JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$13.83
+0.27 (+1.99%)
Open$13.73
Previous Close$13.56
Day High$14.02
Day Low$13.62
52W High$35.34
52W Low$12.12
Volume—
Avg Volume833.0K
Market Cap849.82M
P/E Ratio—
EPS$-1.83
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+255.0% upside
Current
$13.83
$13.83
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.02M | 9.53M | 135.69M |
| Net Income | -113,822,266 | -97,450,570 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -155,909,688 | -140,900,117 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |